Title : Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.

Pub. Date : 2017 Jan 17

PMID : 28095881






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The pre-specified endpoint of mean (SE) change in eGFR from baseline to month 12 was +0.7 (0.9) mL/min/1.73 m2 with high ferritin FCM (p = 0.15 versus oral iron), -0.9 (0.9) mL/min/1.73 m2 with low ferritin FCM (p = 0.99 versus oral iron) and -0.9 (0.7) mL/min/1.73 m2 with oral iron. ferric carboxymaltose epidermal growth factor receptor Homo sapiens